Asia Pacific Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.

Press releases published on March 30, 2026

Mar. 30, 2026

Redevances OR dépose ses documents d’information de fin d’année 2025

Indeterminate GlobeNewswire

Mar. 30, 2026

コートヤード・プーケット・パトンビーチリゾートにて、プーケットのソンクラーンを優雅にご体験ください。

Indeterminate EIN Presswire

Mar. 30, 2026

SHE-QONOMI: Committed to Inclusivity, Accessibility & Sustainability, Podcasts & Data Powered By HER

Indeterminate EIN Presswire

Mar. 30, 2026

Ero Files Technical Report for the Furnas Copper-Gold Project

Indeterminate GlobeNewswire

Mar. 30, 2026

Chance AI Debuts Visual Agent Technology at Art Central Hong Kong

Indeterminate GlobeNewswire

Mar. 30, 2026

New Income Tax Act 2025: Key Changes After Budget 2026

Indeterminate EIN Presswire

Mar. 30, 2026

KRISHH Live in Concert: Soulful Hits with Star Supporting Artistes at N9 Arena

Indeterminate EIN Presswire

Mar. 30, 2026

Hengtong Optic-Electric Achieves EcoVadis Gold Medal on Debut, Ranking Among the Top 5% of Companies Globally

Indeterminate EIN Presswire

Mar. 30, 2026

Ruanyun Edai Technology Inc. Announces 1H 2026 Unaudited Interim Financial Results

Indeterminate GlobeNewswire

Mar. 30, 2026

BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Indeterminate GlobeNewswire

Mar. 30, 2026

Babies4.US: The World’s First Virtual Fertility Platform Launched in North America

Indeterminate EIN Presswire

Mar. 30, 2026

Invivyd Announces Presentation at the World Vaccine Congress Washington

Indeterminate GlobeNewswire

Mar. 30, 2026

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Mar. 30, 2026

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

Indeterminate GlobeNewswire

Mar. 30, 2026

RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 30, 2026

Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease

Indeterminate GlobeNewswire

Mar. 30, 2026

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

Indeterminate GlobeNewswire

Mar. 30, 2026

gateretail and JK Tech Partner to Advance AI-Powered Inflight Retail Intelligence

Indeterminate EIN Presswire

Mar. 30, 2026

UQPAY Launches Enterprise-Grade Card Issuing Capabilities for AI Agents

Indeterminate EIN Presswire

Mar. 30, 2026

Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54

Indeterminate GlobeNewswire